Literature DB >> 26589915

FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.

Haiyan Qin1, Qing Wu1, John K Cowell1, Mingqiang Ren2.   

Abstract

Entities:  

Keywords:  acute myeloid leukemia; aggressive non-Hodgkin lymphoma; cytogenetics and molecular genetics

Mesh：

Substances：

Year:  2015        PMID： 26589915      PMCID： PMC4815735          DOI： 10.3324/haematol.2015.137695

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.

Authors:  Effie K Grand; Francis H Grand; Andrew J Chase; Fiona M Ross; Martin M Corcoran; David G Oscier; Nicholas C P Cross
Journal:  Genes Chromosomes Cancer       Date:  2004-05       Impact factor: 5.006

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

Authors:  Ting-Lei Gu; Valerie L Goss; Cynthia Reeves; Lana Popova; Julie Nardone; Joan Macneill; Denise K Walters; Yi Wang; John Rush; Michael J Comb; Brian J Druker; Roberto D Polakiewicz
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

4.  The BCR gene encodes a novel serine/threonine kinase activity within a single exon.

Authors:  Y Maru; O N Witte
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

Review 5.  Notch signaling in the immune system.

Authors:  Freddy Radtke; Nicolas Fasnacht; H Robson Macdonald
Journal:  Immunity       Date:  2010-01-29       Impact factor: 31.745

6.  Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines.

Authors:  A J Furley; B R Reeves; S Mizutani; L J Altass; S M Watt; M C Jacob; P van den Elsen; C Terhorst; M F Greaves
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

7.  Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.

Authors:  Audrey Lin; Akishige Hokugo; Jae Choi; Ichiro Nishimura
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.

Authors:  Mingqiang Ren; Xiurong Li; John K Cowell
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

10.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941
View more
  9 in total

1.  Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.

Authors:  Sylvain Mareschal; Anna Palau; Johan Lindberg; Philippe Ruminy; Christer Nilsson; Sofia Bengtzén; Marie Engvall; Anna Eriksson; Anne Neddermeyer; Vinciane Marchand; Monika Jansson; My Björklund; Fabrice Jardin; Mattias Rantalainen; Andreas Lennartsson; Lucia Cavelier; Henrik Grönberg; Sören Lehmann
Journal:  Blood Adv       Date:  2021-02-23

2.  Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.

Authors:  John K Cowell; Haiyan Qin; Tianxiang Hu; Qing Wu; Aaron Bhole; Mingqiang Ren
Journal:  Int J Cancer       Date:  2017-07-28       Impact factor: 7.396

3.  CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.

Authors:  Daniel Hwang; Maryam S Seyedsadr; Larissa Lumi Watanabe Ishikawa; Alexandra Boehm; Ziver Sahin; Giacomo Casella; Soohwa Jang; Michael V Gonzalez; James P Garifallou; Hakon Hakonarson; Weifeng Zhang; Dan Xiao; Abdolmohamad Rostami; Guang-Xian Zhang; Bogoljub Ciric
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-30       Impact factor: 12.779

4.  The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.

Authors:  Tianxiang Hu; Yating Chong; Haiyan Qin; Eiko Kitamura; Chang-Sheng Chang; Jeane Silva; Mingqiang Ren; John K Cowell
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

5.  Targeting the RNA-Binding Protein QKI in Myeloid Cells Ameliorates Macrophage-Induced Renal Interstitial Fibrosis.

Authors:  Ruben G de Bruin; Gillian Vogel; Jurrien Prins; Jacques M J G Duijs; Roel Bijkerk; Hendrik J P van der Zande; Janine M van Gils; Hetty C de Boer; Ton J Rabelink; Anton Jan van Zonneveld; Eric P van der Veer; Stéphane Richard
Journal:  Epigenomes       Date:  2020-02-13

6.  GZD824 as a FLT3, FGFR1 and PDGFRα Inhibitor Against Leukemia In Vitro and In Vivo.

Authors:  Yuting Wang; Lenghe Zhang; Xia Tang; Jinfeng Luo; Zhengchao Tu; Kaili Jiang; Xiaomei Ren; Fang Xu; Shingpan Chan; Yuhua Li; Zhang Zhang; Ke Ding
Journal:  Transl Oncol       Date:  2020-04-01       Impact factor: 4.243

7.  FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.

Authors:  Tianxiang Hu; Qing Wu; Yating Chong; Haiyan Qin; Candace J Poole; Jan van Riggelen; Mingqiang Ren; John K Cowell
Journal:  Leukemia       Date:  2018-04-02       Impact factor: 11.528

8.  Expression of Viral microRNAs in Serum and White Blood Cells of Cows Exposed to Bovine Leukemia Virus.

Authors:  Eduardo Casas; Hao Ma; John D Lippolis
Journal:  Front Vet Sci       Date:  2020-09-22

9.  Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.

Authors:  Yun Liu; Baohuan Cai; Yating Chong; Hualei Zhang; Chesley-Anne Kemp; Sumin Lu; Chang-Sheng Chang; Mingqiang Ren; John K Cowell; Tianxiang Hu
Journal:  Cell Death Dis       Date:  2020-10-20       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.